Satisfaction with the treatment result was measured as the patients’ level of satisfaction on a 5-point Likert scale and their willingness to undergo the treatment again under similar circumstances. We performed additional hypothesis testing on 2306 patients who also completed the Michigan Hand Outcomes Questionnaire (MHQ). Construct validity was evaluated using hypothesis testing in which we correlated the patients’ level of satisfaction to the willingness to undergo the treatment again, VAS scores, and the NPS. We included 3742 patients who completed the Satisfaction with Treatment Result Questionnaire, VAS, and the Net Promotor Score (NPS) at 3 months. For the construct validity sample, data collection took place between January 2012 and May 2020. Test-retest reliability was evaluated with a mean time difference of 7.2 ± 1.6 days. For the test-retest sample, data collection took place between February 2020 and May 2020, and we included 174 patients at the end of their treatment with complete baseline data that included both the primary test and the retest. This was a prospective study using two samples: a test-retest reliability sample and a construct validity sample.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |